The Company's business strategy is to capitalize on its expertise in HIFU and its position in urology to achieve long-term growth as a leader in the development, production, marketing and distribution of minimally-invasive medical devices for urological and other indications, primarily using HIFU technology. The Company believes that minimally-invasive treatments using HIFU could provide an alternative to current invasive therapies on the basis of reduced cost and minimized side effects for a number of different indications.

The key elements of the Company's strategy to achieve that objective include:

Provide Minimally-Invasive Solutions to Prostate Cancer using HIFU.

Building upon its established position in the ESWL market, the Company is striving to become a leading provider of minimally- invasive treatment alternatives for prostate cancer, the incidence of which the Company believes will increase as the male population ages in developed countries.
The Company believes that HIFU could represent an alternative to surgery, external beam radiotherapy, brachytherapy and cryotherapy for the treatment of organ-confined prostate cancer without the cost, in-patient hospitalization and adverse side effects associated with those therapies.

Achieve Long-Term Growth by Expanding HIFU Applications Beyond Urology.

The Company's long-term growth strategy is to apply its HIFU technology toward the minimally-invasive treatment of indications beyond urological disorders. The Company believes that HIFU could represent an alternative to surgery and radiotherapy for the treatment of many tumors without the cost, in-patient hospitalization and adverse side effects associated with those therapies.

Capitalize on its current ESWL intalled base and distribution platform in urology

The Company's long term growth strategy is to expand its leadership in the development, production, marketing and distribution of minimally invasive devices, based on its already extensive installed base of ESWL products, and to offer its established distribution platform in urology to other developers of medical technologies

Provide manufacturing solutions to other developers of medical technologies

Building upon its established position in the high-tech medical devices market, the company's strategy is to become a leading provider of manufacturing alternatives to other developers of medical technologies.